Kalkine has a fully transformed New Avatar.
Image Source : Krish Capital Pty Ltd
Index Update: The S&P/ASX 200 surged 1.37% or 118.20 points on Friday to close at 8,757.20, marking a new 100-day high. The benchmark index rose 2.06% over the past five sessions and now sits just 0.22% below its 52-week peak. All eleven sectors closed in positive territory, led by health care with gains at +2.47%, followed by materials (+2.06%) and IT (+1.50%).
Macro Update: Growing instability in U.S. financial markets could have far-reaching global consequences, with economists warning that a potential dismissal of Fed Chair Jerome Powell by Donald Trump may trigger a spike in long-term U.S. Treasury yields and a decline in the US dollar. Such moves risk destabilising global financial systems, as many central banks hold large reserves in dollar-denominated assets. With the U.S. dollar used in nearly 90% of cross-border payments, any disruption could have widespread ripple effects..
Top Market Movers: Mesoblast Limited (ASX: MSB) topped the ASX gainers, surging 34.6% to close at AUD 2.41. Clarity Pharmaceuticals (ASX: CU6) advanced 11.8% to AUD 3.89, while Liontown Resources (ASX: LTR) rose 10.1% to AUD 0.93. On the downside, Yancoal Australia (ASX: YAL) led losses, slipping 5.8% to AUD 5.84. Medibank Private (ASX: MPL) declined 2.5% to AUD 5.02, and Endeavour Group (ASX: EDV) eased 2.4% to AUD 4.03.
Commodity Update: The dollar was poised for a second consecutive weekly gain, supported by strong U.S. economic data, suggesting the Federal Reserve may delay further rate cuts. Gold dipped 0.05% to USD 3343.60, while silver rose 0.62% to USD 38.54 and copper advanced 0.51% to USD 9,723.65. Brent crude inched up 0.04% to USD 69.48 amid concerns over potential Iraqi oil supply disruptions and uncertainty surrounding U.S. tariff policy, which is impacting demand.
Our Stance: Australian equities extended their upward momentum, with the S&P/ASX 200 hitting a 100-day high, reflecting broad investor confidence despite looming global uncertainties. Gains across all sectors, particularly Health Care and Materials, signal solid domestic fundamentals. However, the global macro backdrop remains fragile. The potential upheaval in U.S. financial policy, particularly speculation over Fed leadership, threatens to disrupt currency and debt markets globally. For now, Australian market sentiment appears resilient. Market participants should stay alert to external shocks, especially from the U.S., which could quickly reverse the current scenario in Australian markets.
In its latest trading session, the S&P/ASX 200 Index rose 118.20 points to close at 8,757.20, supported by a bullish candlestick pattern and strong trading volumes, which signal continued investor confidence and enthusiasm. Technically, the index remains firmly above its 21-period Simple Moving Average (SMA), reinforcing a near-term positive outlook. A key support level to watch is 8,680.70. A decisive breakout above this threshold could mark a significant bullish development, potentially reshaping market sentiment and opening the door for further gains. From a broader perspective, the index’s position above the 50-period SMA on the weekly chart further solidifies its long-term bullish foundation, indicating that the underlying trend remains intact and supportive of continued upward momentum
This article has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine. Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate to your objectives, financial situation and needs before acting upon it. There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product. Please note past performance is neither an indicator nor a guarantee of future performance. You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice/information in this article or on the Kalkine website. Not all investments are appropriate for all people. The information in this article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its articles, newsletters and websites. All information represents our views at the date of publication and may change without notice. Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this article, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law. Please also read our Terms & Conditions and Financial Services Guide for further information. On the date of publishing this article (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website unless those persons comply with certain safeguards, procedures, and disclosures. Some of the images/music that may be used in the article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the article unless stated otherwise. The images/music that may be used in the article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary. Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.